Credit Agricole
TEVA icon

Credit Agricole’s Teva Pharmaceuticals TEVA Stock Holding History

Credit Agricole’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$722K Sell
23,956
-1,512
-6% -$48.6K ﹤0.01% 1136
2025
Q4 		$795K Buy
25,468
+4,818
+23% +$119K ﹤0.01% 1094
2025
Q3 		$417K Buy
+20,650
New +$363K ﹤0.01% 1041
2025
Q1 		$405K Sell
26,360
-51,948
-66% -$928K ﹤0.01% 1048
2024
Q4 		$1.73M Sell
78,308
-23,830
-23% -$434K 0.01% 783
2024
Q3 		$1.84M Hold
102,138
– – 0.01% 637
2024
Q2 		$1.66M Buy
102,138
+21,100
+26% +$325K 0.01% 609
2024
Q1 		$1.04M Buy
81,038
+76,538
+1,701% +$965K 0.01% 550
2023
Q4 		$47K Hold
4,500
– – ﹤0.01% 792
2023
Q3 		$45.9K Hold
4,500
– – ﹤0.01% 790
2023
Q2 		$33.9K Hold
4,500
– – ﹤0.01% 560
2023
Q1 		$39.8K Hold
4,500
– – ﹤0.01% 517
2022
Q4 		$41K Hold
4,500
– – ﹤0.01% 537
2022
Q3 		$36K Hold
4,500
– – ﹤0.01% 539
2022
Q2 		$34K Buy
+4,500
New +$39.2K ﹤0.01% 535
2021
Q2 		– Sell
-1,000
Closed -$12K – 741
2021
Q1 		$12K Hold
1,000
– – ﹤0.01% 565
2020
Q4 		$10K Hold
1,000
– – ﹤0.01% 504
2020
Q3 		$9K Hold
1,000
– – ﹤0.01% 461
2020
Q2 		$12K Hold
1,000
– – ﹤0.01% 405
2020
Q1 		$9K Buy
1,000
+999
+99,900% +$10.2K ﹤0.01% 415
2019
Q4 		$0 Hold
1
– – ﹤0.01% 624
2019
Q3 		$0 Sell
1
-1,455
-100% -$11.1K ﹤0.01% 633
2019
Q2 		$13K Hold
1,456
– – ﹤0.01% 435
2019
Q1 		$23K Hold
1,456
– – ﹤0.01% 413
2018
Q4 		$22K Hold
1,456
– – ﹤0.01% 419
2018
Q3 		$31K Hold
1,456
– – ﹤0.01% 392
2018
Q2 		$35K Hold
1,456
– – ﹤0.01% 344
2018
Q1 		$25K Hold
1,456
– – ﹤0.01% 319
2017
Q4 		$28K Sell
1,456
-53,082
-97% -$799K ﹤0.01% 335
2017
Q3 		$961K Sell
54,538
-130,648
-71% -$2.94M ﹤0.01% 1113
2017
Q2 		$6.15M Sell
185,186
-357,859
-66% -$11.1M 0.02% 644
2017
Q1 		$31.8M Buy
543,045
+9,170
+2% +$313K 0.1% 259
2016
Q4 		$19.4M Buy
533,875
+87,983
+20% +$3.51M 0.06% 326
2016
Q3 		$20.5M Sell
445,892
-556,200
-56% -$29M 0.07% 328
2016
Q2 		$50.3M Buy
1,002,092
+564,492
+129% +$30.1M 0.19% 122
2016
Q1 		$23.4M Sell
437,600
-583,296
-57% -$34.2M 0.11% 232
2015
Q4 		$67M Buy
1,020,896
+57,205
+6% +$3.54M 0.31% 70
2015
Q3 		$54.4M Buy
963,691
+465,421
+93% +$30.2M 0.27% 72
2015
Q2 		$29.4M Sell
498,270
-12,621
-2% -$779K 0.14% 174
2015
Q1 		$31.8M Buy
510,891
+44,400
+10% +$2.58M 0.14% 166
2014
Q4 		$26.7M Buy
466,491
+160,600
+53% +$8.95M 0.11% 207
2014
Q3 		$16.4M Buy
305,891
+235,091
+332% +$12.5M 0.07% 315
2014
Q2 		$3.71M Sell
70,800
-87,912
-55% -$4.49M 0.02% 717
2014
Q1 		$8.39M Buy
+158,712
New +$7.34M 0.03% 485

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole's TEVA Position: Q1 2026 in Review

Credit Agricole reduced its Teva Pharmaceuticals (TEVA) stake by 5.9% in Q1 2026, selling an estimated $48.6K and leaving 23,956 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Credit Agricole first reported a position in TEVA in Q1 2014 and has held it in 44 quarters since. The position peaked at $67M in Q4 2015. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Credit Agricole held 23,956 shares of Teva Pharmaceuticals worth $722K as of Q1 2026.
  • Credit Agricole sold 1,512 Teva Pharmaceuticals shares in Q1 2026, an estimated $48.6K.
  • Teva Pharmaceuticals made up ﹤0.01% of Credit Agricole's portfolio in Q1 2026, its #1136 holding.
  • Credit Agricole first reported a position in Teva Pharmaceuticals in Q1 2014 and has held it in 44 quarters since.
  • Credit Agricole's Teva Pharmaceuticals position peaked at $67M in Q4 2015.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Credit Agricole's 13F filing for Q1 2026, filed 15 May 2026.